Characterizations of Clinical Isolates of Clostridium difficile by Toxin Genotypes and by Susceptibility to 12 Antimicrobial Agents, Including Fidaxomicin (OPT-80) and Rifaximin: a Multicenter Study in Taiwan

Antimicrobial Susceptibilities and Molecular Epidemiology of Clinical Isolates ofClostridium difficilein Taiwan

(2011) Yi-Chun Lin et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Comparative Susceptibilities to Fidaxomicin (OPT-80) of Isolates Collected at Baseline, Recurrence, and Failure from Patients in Two Phase III Trials of Fidaxomicin against Clostridium difficile Infection

(2011) Ellie J. C. Goldstein et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Faecal pharmacokinetics of orally administered vancomycin in patients with suspected Clostridium difficile infection

(2011) Milagros Gonzales et al.   BMC INFECTIOUS DISEASES

New target for inhibition of bacterial RNA polymerase: ‘switch region’

(2011) Aashish Srivastava et al.   CURRENT OPINION IN MICROBIOLOGY

Comparison of the Burdens of Hospital-Onset, Healthcare Facility-Associated Clostridium difficile Infection and of Healthcare-Associated Infection due to Methicillin-Resistant Staphylococcus aureus in Community Hospitals

(2011) Becky A. Miller et al.   INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY

A randomized, double-blind, placebo-controlled pilot study to assess the ability of rifaximin to prevent recurrent diarrhoea in patients with Clostridium difficile infection

(2011) K. W. Garey et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Fidaxomicin: A Macrocyclic Antibiotic for the Treatment ofClostridium difficileInfection

(2011) Jennifer S Hardesty et al.   PHARMACOTHERAPY

Clinical Clostridium difficile: Clonality and Pathogenicity Locus Diversity

(2011) Kate E. Dingle et al.   PLoS One

Quinolone Resistance: Much More than Predicted

(2011) Alvaro Hernández et al.   Frontiers in Microbiology

Antimicrobial susceptibility and heteroresistance in Chinese Clostridium difficile strains

(2010) Haihui Huang et al.   ANAEROBE

Molecular characterization of moxifloxacin resistance from Canadian Clostridium difficile clinical isolates

(2010) Andrew Walkty et al.   DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE

Clinical Practice Guidelines for Clostridium difficile Infection in Adults: 2010 Update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA)

(2010) Stuart H. Cohen et al.   INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY

Clostridium difficile Isolates Resistant to Fluoroquinolones in Italy: Emergence of PCR Ribotype 018

(2010) P. Spigaglia et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Clostridium difficile Infection at a Medical Center in Southern Taiwan: Incidence, Clinical Features and Prognosis

(2010) Chih-Huan Chung et al.   JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION

Investigation of Toxin Gene Diversity, Molecular Epidemiology, and Antimicrobial Resistance ofClostridium difficileIsolated from 12 Hospitals in South Korea

(2010) Heejung Kim et al.   Korean Journal of Laboratory Medicine

Effects of Subinhibitory Concentrations of Antibiotics on Colonization Factor Expression by Moxifloxacin-Susceptible and Moxifloxacin-Resistant Clostridium difficile Strains

(2009) C. Deneve et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Health Care–AssociatedClostridium difficileInfection in Canada: Patient Age and Infecting Strain Type Are Highly Predictive of Severe Outcome and Mortality

(2009) Mark Miller et al.   CLINICAL INFECTIOUS DISEASES

European Society of Clinical Microbiology and Infectious Diseases (ESCMID): treatment guidance document for Clostridium difficile infection (CDI)

(2009) M.P. Bauer et al.   CLINICAL MICROBIOLOGY AND INFECTION

Clostridium difficile Infection Caused by the Epidemic BI/NAP1/027 Strain

(2009) Jennifer R. O'Connor et al.   GASTROENTEROLOGY

Antimicrobial resistance in Clostridium difficile

(2009) Haihui Huang et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Both Oral Metronidazole and Oral Vancomycin Promote Persistent Overgrowth of Vancomycin-Resistant Enterococci during Treatment of Clostridium difficile-Associated Disease

(2008) W. N. Al-Nassir et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Emergence of reduced susceptibility to metronidazole in Clostridium difficile

(2008) S. D. Baines et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Qnr-like pentapeptide repeat proteins in Gram-positive bacteria

(2008) J. M. Rodríguez-Martínez et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Rifaximin in Treatment of Recurrent Clostridium difficile-associated Diarrhea: An Uncontrolled Pilot Study

(2008) Kevin W. Garey et al.   JOURNAL OF CLINICAL GASTROENTEROLOGY

Fluoroquinolone resistance in Clostridium difficile isolates from a prospective study of C. difficile infections in Europe

(2008) P. Spigaglia et al.   JOURNAL OF MEDICAL MICROBIOLOGY